Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Khan, H. G. Articles by Murphy, K. J. Search for Related Content PubMed PubMed Citation Articles by Khan, H. G. Articles by Murphy, K. J.

American Journal of Neuroradiology 21:386-390 (2 2000)
© 2000 American Society of Neuroradiology

ARTICLE

The Effect of Contrast Material on Transcranial Doppler Evaluation of Normal Middle Cerebral Artery Peak Systolic Velocity

Haleem G. Khan^a, Philippe Gailloud^a, Ronald O. Bude^a, Jean-Baptiste Martin^a, Kazimierz T. Szopinski^a, Christophe Khaw^a, Daniel A. Rüfenacht^a and Kieran J. Murphy^,a

^a From the Division of Diagnostic and Interventional Radiology (H.G.K, P.G., J.-B.M, C.K., D.A.R., K.J.M.), Geneva University Hospital, Geneva, Switzerland; the Department of Radiology (R.O.B.), Ann Arbor, MI; and the Department of Radiology and Radiological Sciences (P.G., K.T.S., K.J.M.), Johns Hopkins Hospital, Baltimore, MD.

BACKGROUND AND PURPOSE: Several recent studies have shown that sonographic contrast agents may affect transcranial Doppler evaluation of the arterial peak systolic velocity (PSV). Some investigators reported an increase in PSV, and others reported no change in PSV compared with baseline values. This study was conducted to determine the effect of sonographic contrast agent on PSV measured in normal middle cerebral arteries.

METHODS: Continuous spectral Doppler sonography was performed on the right middle cerebral artery of 20 participants with angiographically proven normal intracranial vasculature. Videotaping was performed in each case from the initiation of the administration of contrast medium until the effect of the contrast agent on the PSV subsided. The PSV values were normalized for each participant, were pooled, and were plotted as a function of time.

RESULTS: PSV increased in all participants after the administration of contrast material; the mean maximum increase was 24 ± 7.4% (mean ± standard deviation) (range, 15-36%). The mean duration of PSV increase was 320 ± 97 s (range, 165-465 s).

CONCLUSION: The middle cerebral artery PSV increased substantially after the administration of contrast material. This effect needs to be considered if velocity thresholds developed for disease detection without the use of contrast materials are used when contrast agents are administered.

This article has been cited by other articles:

				M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, May 11, 2004; 62(9): 1468 - 1481. [Abstract] [Full Text] [PDF]

				P. Zunker, H. Wilms, J. Brossmann, D. Georgiadis, S. Weber, and G. Deuschl Echo Contrast-Enhanced Transcranial Ultrasound: Frequency of Use, Diagnostic Benefit, and Validity of Results Compared With MRA Stroke, November 1, 2002; 33(11): 2600 - 2603. [Abstract] [Full Text] [PDF]

				G. Deklunder Role of ultrasound and contrast-enhanced ultrasound in patients with cerebrovascular disease Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C51 - C55. [Abstract] [PDF]